|
HS Code |
564197 |
| Generic Name | Amrinone |
| Brand Name | Inocor |
| Drug Class | Phosphodiesterase III inhibitor |
| Mechanism Of Action | Increases intracellular cAMP, leading to increased cardiac contractility and vasodilation |
| Route Of Administration | Intravenous |
| Indication | Short-term management of congestive heart failure |
| Molecular Formula | C10H9N3O |
| Molecular Weight | 187.20 g/mol |
| Half Life | 5 to 8 hours |
| Side Effects | Thrombocytopenia, arrhythmias, hypotension, liver enzyme abnormalities |
| Contraindications | Severe aortic or pulmonic valvular disease |
| Metabolism | Hepatic and renal (excreted in urine) |
| Pregnancy Category | C |
| Appearance | Yellow crystalline powder |
| Storage Temperature | 20°C to 25°C (68°F to 77°F) |
As an accredited Amrinone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amrinone is packaged in a clear glass vial containing 20 mL injectable solution, labeled with concentration, usage instructions, and safety warnings. |
| Shipping | Amrinone is shipped as a stable solid, packaged in tightly sealed containers to protect from moisture and light. It is classified as non-hazardous for transport, but proper labeling and documentation are required. Shipments should comply with relevant chemical safety and regulatory guidelines to ensure secure and compliant delivery. |
| Storage | Amrinone should be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It must be kept in a tightly closed container, protected from light and moisture. Store away from incompatible substances and keep out of reach of children. Proper storage ensures chemical stability and prevents degradation or contamination of Amrinone. |
Applications of Amrinone in Industrial ManufacturingAs a dedicated manufacturer of pharmaceutical-grade Amrinone, we provide high quality product streams tailored to the rigorously regulated requirements of industry clients. Amrinone’s core industrial use lies within the specialized pharma sector, while select contract research and analytical supply chains also utilize this material under strictly defined protocols. We outline the primary application channels below, highlighting regulatory frameworks, specific ratios, process roles, and representative downstream outputs. 1. Injectable Cardiovascular Drug ManufacturingAmrinone serves as a critical active pharmaceutical ingredient (API) for the production of sterile cardiovascular injectables, particularly for acute management of congestive heart failure and cardiac output support. Pharmaceutical processors source Amrinone for compounding in cleanroom environments, following validated aseptic techniques and in full compliance with regulated GMP standards. Production requires strict in-process QC, control of residual solvents, and stability profiling to meet finished dosage specifications. Our material supports downstream formulation into injectable ampoules and ready-to-use vials, maintaining batch traceability throughout. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Contract Drug Formulation DevelopmentCRO and CDMO partners procure Amrinone for use in pre-formulation and investigational drug product development. Research teams utilize our pharmaceutical-grade lots for solution studies, stability evaluation, vehicle compatibility trials, and prototype dosage form development. Compounders adhere to international guidelines for laboratory-scale batch trials, ensuring documented traceability and non-clinical use consistent with IND-enabling studies. Our technical support assists in documentation of source and analytical profile for client filings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Analytical Reference Standard ProductionAccredited laboratories, pharmaceutical QC departments, and analytical kit suppliers utilize highly pure Amrinone as a reference material for impurity profiling, traceability studies, and validation of analytical methods as required during ongoing commercial drug product testing. Our batches supply critical system suitability and calibration for HPLC, LC-MS, and dissolution sampling workflows. Accurate source documentation and full spectral analysis accompany every shipment to support regulatory acceptance of test results. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Cardiac Research Reagent SupplyUniversity medical research groups and preclinical R&D facilities source Amrinone to study cardiac muscle contractility, cellular ion signaling, and pharmacologic modulation in vitro or in non-clinical animal models. Our GMP-compliant manufacturing and batch-level documentation enable direct use for dose-ranging and mechanistic research, with physiologic or pharmacodynamic endpoints validated against reference controls. All deliveries ship with certificates to support institutional review and grant documentation needs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Amrinone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Amrinone stands as one of the signature products from our facility, and over the years, our teams have honed both method and mindset to ensure consistency at every stage. We do not just manufacture molecules—we monitor every batch, from raw material sourcing to packaging. This hands-on approach matters most with compounds like Amrinone, which call for precision and a history of quality control.
Work with Amrinone has taught us that attention to detail is more than a checkbox ― it influences research outcomes, pharmaceutical formulation, and reliability in critical care manufacturing. In its purest form, Amrinone frequently appears as a pale to off-white crystalline powder, and batches emerging from our purification lines consistently meet the highest expectations for clarity and stability.
In cardiac and pharmacological research, precision determines outcomes. Scientists rely on regents like Amrinone to study cardiac inotropic agents, and reliability often comes down to the confidence a team has in its chemical supplier. Each order is tracked and analyzed internally, and our experts examine every lot to ensure that melting point, chemical assay, and residue levels conform with stringent protocols.
In direct manufacturing, the absence of intermediaries provides better control over every specification. We produce Amrinone (model: intermediate or active grade, as required) under GMP-aligned protocols in facilities certified to national and export standards. Our process integrates solution-phase and crystallization purity checks at every step, crafting Amrinone consistently above 99% purity by HPLC and ensuring minimal residual solvents or heavy metals.
Our experience tells us that minor deviations in synthesis can lead to significant downstream variations in performance, so we invest in analytics and controls rather than shortcuts. Customers expect tight specifications – such as assay results, moisture content below 0.5%, precise melting range, and low impurity profile – and we structure every batch record to reflect these real-world needs.
Manufacturers see first-hand how environmental factors alter sensitive intermediates. We package Amrinone in airtight, moisture-resistant containers to prevent degradation. High-value materials need real-world protection from humidity and temperature fluctuations, so each shipment is packed and sealed in dedicated areas—never on shared lines or in cross-contaminated spaces.
We store finished Amrinone in temperature-controlled rooms until it enters the logistics pipeline, and every employee signs off on chain-of-custody documentation. No shortcuts, no repackaging, no compromise. That’s the mindset demanded by critical path chemicals like Amrinone.
Often, customers switching from trading companies to direct manufacturers tell us about inconsistencies and opacity in sourcing. Distributors may not always reveal the true origin or modification history of the product. Here, direct sourcing makes all the difference. Chemists control the entire process—right from procurement of starting materials to shipment. Any adjustment is traced, documented, and discussed in our technical reviews.
Our Amrinone does not pass through multiple handlers, so customers receive material with full transparency and access to batch records. Our teams field questions directly, providing not only technical sheets but in-depth insights earned by troubleshooting and optimizing production. This transparency builds long-term relationships; we know our customers by name, they know our line leads, and ongoing improvement comes as a joint effort.
The experience of seeing an order through, from reactor load-in to final release, shapes a manufacturer’s mindset. In-house QC teams lead all batch verifications, ensuring identity, potency, and impurity limits before the product moves into the warehouse. Regulatory audits visit us often, which keeps our process documentation and training sharp. We integrate batch-level traceability, placing QR codes and tracking numbers on every drum and package, so customers trace lot details at any stage—long after initial delivery.
This tight control brings peace of mind to formulation chemists and procurement managers alike. They know they are receiving consistent, vetted Amrinone—never relabeled, never mixed from old stock, and always matched to the original production specification.
As demand for cardiac research chemicals grows, our teams periodically assess and upgrade reactor systems, solvent management, and impurity profiling techniques. Scale-up brings new challenges, so we adapt production lines and analytical equipment to preserve purity and batch-to-batch reproducibility. Employees see and solve challenges first-hand, feeding practical improvements back into R&D. For example, minor process tweaks—such as improved temperature ramping or solvent recycling—stem from collective insight developed on the shop floor.
Production scale introduces risks—contamination, cross-batch error, sluggish filtration. Our experienced operators anticipate and resolve these hurdles before material exits the plant. Laboratory validation follows every system improvement, and we share learning outcomes between shifts and departments, closing the gap between process theory and practice.
Lab-scale Amrinone synthesis looks straightforward, but commercial production exposes material to a range of real-world variables—power surges, water quality shifts, supply chain interruptions. Manually checking each analytical result and cross-verifying with standards helps avoid unnoticed drift. Work in a regulated plant does not leave room for guesswork; we encourage reporting and tracing any deviation, and batch investigation becomes a routine, not an exception.
Quality comes from more than certificates. It comes from staff with years of hands-on experience, supervisors who know the quirks of every reactor, and a culture of respect for procedure. Veteran operators spot a problem load by sight, catch crystals before growth issues appear, and flag solvent anomalies before QC sees a result out of range.
Working decades in the field, practical knowledge accumulates. Customers running large screening programs often teach us what works in application, not just on paper. For example, minor differences in solvent residue can impact assay work or result in extra clean-up at the end-user lab. Repeat buyers catch on quickly if there’s a difference between lots; delivering material that performs as expected year after year, regardless of external conditions, has helped us secure enduring relationships based on trust.
Consistent, reliable shipments enable researchers and developers to plan projects around real delivery timelines. We honor every commitment, working with logistics teams who have handled pharmaceutical intermediates for as long as we have. Feedback from global clients helps us readjust handling practices and anticipate new regulatory or market needs.
With today’s regulatory demands, traceability cannot be optional. Vigilant record-keeping comes as the rule rather than the exception. In every Amrinone batch, we assign traceable lot codes and maintain audit-ready logs at every hand-off. This cuts down on questions in audits, eliminates finger-pointing between supplier and customer, and ensures prompt support any time a client reviews material origins or compliance records.
If regulators or end users need clarification, our plant records stand ready. All employees are trained on data integrity and reporting; we review every production and packaging record in real time so oversight stays integral, never an afterthought.
As new countries revise their import laws and documentation expectations, our compliance team keeps batch records aligned with every market. We keep lines open with foreign regulatory bodies and update certificates, safety profiles, and export packs in response to shifting global standards. Wherever Amrinone travels, its documentation matches the highest expectation of local authorities—whether European, North American, or Asian standards.
Maintaining compliance means close readings of changing rules as well as exchanges with regulatory officers, not only filling out templates but fielding site visits and answering real questions about technique. Batch records must stand up to scrutiny in unexpected audits; feedback sharpens our operation, pushing toward zero-defect shipments.
Chemical production has evolved, and responsible manufacturers invest in environmental, safety, and waste reduction practices. For Amrinone, our plant tracks solvent use, recovery, and safe destruction of off-spec lots. Efforts to use greener reagents stem from field experience—operators plan waste neutralization and recovery during every shift, improving both environmental and economic performance.
Our plant managers invest in worker safety, maintaining rigorous air handling, closed handling systems, and regular safety drills. Employees have authority to shut down any operation presenting risk to people or product, and utility teams stay on-call to address any process interruption.
Each production run brings new lessons, and we keep feedback cycles open between floor staff and technical management. If one operator discovers an impurity trend, it becomes a shared concern. We invite outside auditors and encourage chemist exchange; every visit brings an insight or best practice that can be applied or improved upon internally.
By investing in ongoing learning and upgrading equipment and monitoring tools, the plant reduces waste, improves purity returns, and keeps safety margins high. Involving the workforce at every level, from maintenance crew to shift supervisor, strengthens the company’s skill base and keeps practical knowledge close to the surface.
Our history of technical partnership with pharmaceutical R&D teams gives us an unusual window into changing research needs. As scientists test new formulations or develop improved delivery systems, we match production schedules and packaging solutions to support time-sensitive programs. Custom lot sizing, tailored delivery, and same-day quality assurance reviews rise out of hard-earned experience, not theory.
Strong partnerships grow from solid results. Our technical support team includes former bench chemists and plant supervisors, ready to troubleshoot issues or expedite out-of-cycle shipments. Collaboration, built from years of direct communication, cuts lag time between request and delivery—a feature traders simply cannot supply.
Vertical integration separates a manufacturer from other supply models. In Amrinone production, this fact means every stage unfolds under direct supervision, fostering accountability and real adaptability. If market demand shifts or a raw material shipment delays, we adapt from within, revising batch plans, recalibrating equipment, and consulting our internal supply chain, rather than left waiting on unknowns from outside brokers.
Customers value this assurance. It eliminates uncertainty—both of chain-of-custody and production standards—allowing for predictable planning and minimized inventory risks for formulation teams relying on steady, unbroken supply.
Direct manufacturing builds trust that can withstand market volatility or regulatory flux. We invite customers to review our certifications, run pilot trials, or interview our technical staff. Experience teaches that long-term clients value technical dialogue—questions about impurity identification, reactivity profiles, or custom packaging do not get lost in translation between departments. Everything is discussed in clear language, and we keep our doors open to custom requests or method improvements.
This sense of reliability is built over countless batches, not marketing claims. Our plant culture rejects compromise for the sake of volume. Samples and shipments represent not only a molecule but a history of care, invested labor, and real-world accountability.
Producing Amrinone is more than operating reactors and filling containers—it is a pledge to deliver unbroken consistency, transparency, and responsiveness to customers who entrust us with research and production. In a landscape where shortcutting costs or obscuring origins can run rampant, we anchor every order with a visible record of human effort and technical discipline.
As the industry continues to evolve and expectations for quality rise, manufacturing teams with hands-on insight and willingness to address the full product lifecycle will remain central to progress, trust, and innovation in any field demanding high-performance intermediates. Such is the commitment behind every drum or vial of Amrinone leaving our plant.